Correlation Between AbbVie and Eli Lilly
Can any of the company-specific risk be diversified away by investing in both AbbVie and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Eli Lilly and, you can compare the effects of market volatilities on AbbVie and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Eli Lilly.
Diversification Opportunities for AbbVie and Eli Lilly
Poor diversification
The 3 months correlation between AbbVie and Eli is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of AbbVie i.e., AbbVie and Eli Lilly go up and down completely randomly.
Pair Corralation between AbbVie and Eli Lilly
Given the investment horizon of 90 days AbbVie Inc is expected to generate 0.68 times more return on investment than Eli Lilly. However, AbbVie Inc is 1.47 times less risky than Eli Lilly. It trades about 0.17 of its potential returns per unit of risk. Eli Lilly and is currently generating about 0.05 per unit of risk. If you would invest 17,635 in AbbVie Inc on December 27, 2024 and sell it today you would earn a total of 2,626 from holding AbbVie Inc or generate 14.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
AbbVie Inc vs. Eli Lilly and
Performance |
Timeline |
AbbVie Inc |
Eli Lilly |
AbbVie and Eli Lilly Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AbbVie and Eli Lilly
The main advantage of trading using opposite AbbVie and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.AbbVie vs. Merck Company | AbbVie vs. Pfizer Inc | AbbVie vs. Eli Lilly and | AbbVie vs. Bristol Myers Squibb |
Eli Lilly vs. Emergent Biosolutions | Eli Lilly vs. Bausch Health Companies | Eli Lilly vs. Neurocrine Biosciences | Eli Lilly vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world |